A.sup.21 -, B.sup.30 - modified insulin derivatives having an al
A.sup.21, B.sup.30, modified insulin derivatives having an alter
Amylin antagonist peptides and uses therefor
Biologically active peptides
Biologically active peptides
Cation complexes of insulin compound conjugates, formulation...
Chromatographic process for purification of insulin
Conjugation-stabilized polypeptide compositions, therapeutic del
Crystalline human proinsulin and process for its production
Crystallization of proteins
Crystals of insulin analogs and processes for their preparation
DNA-sequence encoding biosynthetic insulin precursors and proces
Enzymatic removal of a protein amino-terminal sequence
Epitope for prevention of type I diabetes
Human AlaGlu-IGF-1
Human insulin analogs and preparations containing them
IGF-I point variants
IGF-I variants
Insulin analogues
Insulin precursors